| Company Name: |
SPIRO PHARMA |
| Tel: |
|
| Email: |
eric_feng1954@126.com |
| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
CP-810123 manufacturers
- CP-810123
-
- $293.00
-
2026-04-20
- CAS:439608-12-5
- Purity: 99.99%
- Supply Ability: 10g
|
| | CP-810123 Basic information |
| Product Name: | CP-810123 | | Synonyms: | CP-810123;2-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-5-methyl-[1,3]oxazolo[4,5-b]pyridine;UNII-E6G4550EC4;1,4-Diazabicyclo[3.2.2]nonane, 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)- | | CAS: | 439608-12-5 | | MF: | C14H18N4O | | MW: | 258.32 | | EINECS: | | | Product Categories: | | | Mol File: | 439608-12-5.mol |  |
| | CP-810123 Chemical Properties |
| Boiling point | 392.9±52.0 °C(Predicted) | | density | 1.29±0.1 g/cm3(Predicted) | | pka | 9.00±0.20(Predicted) |
| | CP-810123 Usage And Synthesis |
| Uses | CP-810123 is a brain-permeable agonist of α7 nAChR for the research of cognitive impairment associated with psychiatric or neurological disorders such as schizophrenia and Alzheimer's disease[1]. | | References | [1] Jun Toyohara, et al. α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer’s Disease. Open Med Chem J. 2010; 4: 37–56. |
| | CP-810123 Preparation Products And Raw materials |
|